| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |